Efficacy

Favorable safety and tolerability profile related to OCU400…

-  The research study was conducted at the Sahyadri Speciality Hospital, Deccan  PUNE, India, March 1, 2023 /PRNewswire/ -- A research study of efficacy of Mycophenolate in the treatment of Covid-19 by a team of doctors at Sahyadri…

MORRISTOWN, N.J., Jan. 04, 2023 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals, Inc. (Nasdaq: ICPT), a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral liver…

Updated Results from CHARIOT Phase 2 trial presented at the 2022 ASH Annual Meeting indicate a 73.3% overall response rate and 60% complete response rate from 15 heavily pre-treated patients dosed with TT11 Research presented in an…

EDIT-301 was well-tolerated and demonstrated a safety profile consistent with myeloablative conditioning with busulfan and autologous hematopoietic stem cell transplant Both patients treated with EDIT-301 successfully engrafted and are…

-   Data demonstrated that once-weekly TransCon CNP has the potential to meet patient and caregiver needs for a safe, effective, tolerable and convenient treatment -   The primary endpoint, annualized height velocity (AHV) at Week 52,…